Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Apellis Pharmaceuticals, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$apls.png) Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Apellis Pharmaceuticals ($APLS) sees positive sentiment and high social media engagement, but analyst downgrades are causing a price decrease.

### About Apellis Pharmaceuticals, Inc. Common Stock
Apellis Pharmaceuticals, Inc. Common Stock is a healthcare stock.  
Apellis Pharmaceuticals, Inc. Common Stock uses the ticker $APLS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Price: $XXXXX [#](/topic/$apls/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$apls/time-series/close.tsv)  
The stock price is decreasing due to analyst downgrades, despite positive sentiment from clinical trial results and high social media engagement. This suggests the market is reacting more strongly to the analyst downgrades.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXX%  |

**1-Year High**: $XXXXX on 2024-09-06  
**1-Year Low**: $XXXXX on 2025-05-15  
  
  
### AltRank: XXXXX [#](/topic/$apls/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$apls/time-series/alt_rank.tsv)  
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is currently AltRank #1,859 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +882  
**1 Month**: XXXXX +1,083  
**6 Months**: XXXXX +1,404  
**1 Year**: XXXXX +1,198  
**1-Year High**: XXXXX on 2025-06-28  
**1-Year Low**: XX on 2025-01-18  
  
  
### Galaxy Score: XXXXX [#](/topic/$apls/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$apls/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +1  
**1 Month**: XX +10  
**6 Months**: XX +10  
**1 Year**: XX +16  
**1-Year High**: XX on 2025-06-02  
**1-Year Low**: XX on 2024-08-04  
  
  
### Engagements: XXXXX [#](/topic/$apls/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$apls/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX +22%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX +0.65%  
**1-Year High**: XXXXXXX on 2024-12-05  
**1-Year Low**: XXX on 2025-03-30  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$apls/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$apls/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +154%  
**6 Months**: XXXXX -XX%  
**1 Year**: XXXXX +70%  
**1-Year High**: XXX on 2024-11-25  
**1-Year Low**: XX on 2025-03-30  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$apls/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$apls/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Apellis Pharmaceuticals, Inc. Common Stock (APLS) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +337%  
**6 Months**: XXXXX +10%  
**1 Year**: XXXXX +141%  
**1-Year High**: XXX on 2025-06-29  
**1-Year Low**: XX on 2025-03-30  

The most influential creators that mention Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XXXXX       |

[View More](/list/creators/$apls/100)
  
  
### Sentiment: XX% [#](/topic/$apls/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$apls/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% +12%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2024-07-27  
**1-Year Low**: XX% on 2025-03-25  

**Most Supportive Themes**
- **Positive Sentiment and High Engagement:** (70%) Positive sentiment with high engagement suggests a favorable outlook for Apellis Pharmaceuticals.
  
**Most Critical Themes**
- **Analyst Price Target Adjustments:** (20%)  Analyst downgrades are influencing the stock price.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$apls/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$apls/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXXX% -XXXXXXX%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-11-02  
**1-Year Low**: XXXXXX% on 2025-07-16  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$apls/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$apls/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2024-09-07  
**1-Year Low**: XXXXXXX% on 2025-07-18  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$apls/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$apls/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$apls/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$0.10%  
**1 Month**: $XXXXXXXXXXXXX +$9.60%  
**6 Months**: $XXXXXXXXXXXXX -$34%  
**1 Year**: $XXXXXXXXXXXXX -$47%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-09-06  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-05-15  

**Top assets mentioned**
In the posts about Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[GSK plc (GSK)](/topic/$gsk)
[Akropolis (AKRO)](/topic/$akro)
[BounceBit (BB)](/topic/$bb)
[Sleepless AI (AI)](/topic/$ai)
[Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix)
[SuperRare (RARE)](/topic/$rare)
[Agnico Eagle Mines Ltd. (AEM)](/topic/$aem)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)

**Top topics mentioned**
In the posts about Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

[nvda](/topic/nvda), [coins ai](/topic/coins-ai), [spx](/topic/spx), [alt](/topic/alt), [$asnd](/topic/$asnd), [gme](/topic/gme), [$rhhby](/topic/$rhhby), [qqq](/topic/qqq), [$regn](/topic/$regn), [amzn](/topic/amzn), [aes](/topic/aes), [stocks](/topic/stocks), [$repl](/topic/$repl), [pltr](/topic/pltr), [$gsk](/topic/$gsk), [$qntm](/topic/$qntm), [vera](/topic/vera), [$kalv](/topic/$kalv), [op](/topic/op), [$tnxp](/topic/$tnxp), [adm](/topic/adm), [qbts](/topic/qbts), [$1211hk](/topic/$1211hk), [byd](/topic/byd), [nke](/topic/nke), [$akro](/topic/$akro), [$mgx](/topic/$mgx), [$edit](/topic/$edit), [meta](/topic/meta), [$ocul](/topic/$ocul), [hims](/topic/hims), [nasdaq](/topic/nasdaq), [$dwac](/topic/$dwac), [$bb](/topic/$bb), [$ai](/topic/$ai), [plug](/topic/plug), [$mirm](/topic/$mirm), [$urgn](/topic/$urgn), [$rgnx](/topic/$rgnx), [$pure](/topic/$pure), [$prax](/topic/$prax), [clsk](/topic/clsk), [$vrna](/topic/$vrna), [$nbix](/topic/$nbix), [asts](/topic/asts), [dawn](/topic/dawn), [$wppl](/topic/$wppl), [oscr](/topic/oscr), [apt](/topic/apt), [$inmb](/topic/$inmb), [sonn](/topic/sonn), [money](/topic/money), [stockmarket](/topic/stockmarket), [mauritian rupee](/topic/mauritian-rupee), [luv](/topic/luv), [uber eats](/topic/uber-eats), [nio](/topic/nio), [lmt](/topic/lmt), [$veon](/topic/$veon), [$lyel](/topic/$lyel), [$daaqw](/topic/$daaqw), [dd](/topic/dd), [bbgi](/topic/bbgi), [$exk](/topic/$exk), [$dea](/topic/$dea), [pfe](/topic/pfe), [hae](/topic/hae), [$futu](/topic/$futu), [$fsm](/topic/$fsm), [$capr](/topic/$capr), [$tvtx](/topic/$tvtx), [$rare](/topic/$rare), [$alec](/topic/$alec), [$nvct](/topic/$nvct), [$bstz](/topic/$bstz), [$aem](/topic/$aem), [$tars](/topic/$tars), [approved](/topic/approved), [goog](/topic/goog), [radar](/topic/radar), [$srpt](/topic/$srpt), [$srzn](/topic/$srzn), [$eypt](/topic/$eypt), [$olma](/topic/$olma), [$pmtrw](/topic/$pmtrw), [$emcg](/topic/$emcg), [$goss](/topic/$goss), [$dkl](/topic/$dkl), [$tlry](/topic/$tlry), [$trv](/topic/$trv), [$rost](/topic/$rost), [$mcrp](/topic/$mcrp), [$avxl](/topic/$avxl), [$obsv](/topic/$obsv), [$xlo](/topic/$xlo), [telo](/topic/telo), [mira](/topic/mira), [$mth](/topic/$mth), [$mcrb](/topic/$mcrb), [$imcr](/topic/$imcr)

### Top Social Posts [#](/topic/$apls/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$APH -Evercore raises Amphenol target to $XXX from $XXX Outperform - $APLS -Baird raises Apellis Pharmaceuticals target to $XX from $XX Outperform - $AVDL -HC Wainwright initiates Avadel Pharmaceuticals coverage at Buy $XX target -"  
[@MarcJacksonLA](/creator/x/MarcJacksonLA) on [X](/post/tweet/1946255740160909534) 2025-07-18 17:08:22 UTC 7056 followers, XXX engagements


"#ThinkSabio #Trendingstock $SPX $SPY $XBI $QQQ $IWM #Markets #StockMarket #Stocks #Trending @BiO Upcoming Catalyst of Next Week 20-27 2025: July 22: $ONCY $REPL July 23: $GSK July 27: $INMB $ASND $CRVO July 28: $APLS"  
[@thinksabio](/creator/x/thinksabio) on [X](/post/tweet/1946252454691311767) 2025-07-18 16:55:19 UTC XXX followers, XXX engagements


"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"  
[@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1946231638557618231) 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements


"$APLS new alerts have been posted in the last hours-"  
[@HenriettaBrid19](/creator/x/HenriettaBrid19) on [X](/post/tweet/1946216294778577137) 2025-07-18 14:31:38 UTC XX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Apellis Pharmaceuticals, Inc. Common Stock Graphic Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Apellis Pharmaceuticals ($APLS) sees positive sentiment and high social media engagement, but analyst downgrades are causing a price decrease.

About Apellis Pharmaceuticals, Inc. Common Stock

Apellis Pharmaceuticals, Inc. Common Stock is a healthcare stock.
Apellis Pharmaceuticals, Inc. Common Stock uses the ticker $APLS for trading. Listed in the Stocks and category within the Healthcare sectors.

Price: $XXXXX #

Price Line Chart
Price 24-Hour Chart Data
The stock price is decreasing due to analyst downgrades, despite positive sentiment from clinical trial results and high social media engagement. This suggests the market is reacting more strongly to the analyst downgrades.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% XXXX%

1-Year High: $XXXXX on 2024-09-06
1-Year Low: $XXXXX on 2025-05-15

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Apellis Pharmaceuticals, Inc. Common Stock (APLS) is currently AltRank #1,859 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +882
1 Month: XXXXX +1,083
6 Months: XXXXX +1,404
1 Year: XXXXX +1,198
1-Year High: XXXXX on 2025-06-28
1-Year Low: XX on 2025-01-18

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +1
1 Month: XX +10
6 Months: XX +10
1 Year: XX +16
1-Year High: XX on 2025-06-02
1-Year Low: XX on 2024-08-04

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +22%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +0.65%
1-Year High: XXXXXXX on 2024-12-05
1-Year Low: XXX on 2025-03-30

Social Network X
Engagements XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX +154%
6 Months: XXXXX -XX%
1 Year: XXXXX +70%
1-Year High: XXX on 2024-11-25
1-Year Low: XX on 2025-03-30

Social Network X
Mentions XXX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Apellis Pharmaceuticals, Inc. Common Stock (APLS) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +337%
6 Months: XXXXX +10%
1 Year: XXXXX +141%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-03-30

The most influential creators that mention Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@BiopharmIQ X XXXXXX X XXXXX

View More

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% +12%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-27
1-Year Low: XX% on 2025-03-25

Most Supportive Themes

  • Positive Sentiment and High Engagement: (70%) Positive sentiment with high engagement suggests a favorable outlook for Apellis Pharmaceuticals.

Most Critical Themes

  • Analyst Price Target Adjustments: (20%) Analyst downgrades are influencing the stock price.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXX X%
Total XXXXX XX% XXXXX XX% XXX X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% -XXXXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-11-02
1-Year Low: XXXXXX% on 2025-07-16

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXXXX% on 2025-07-18

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.10%
1 Month: $XXXXXXXXXXXXX +$9.60%
6 Months: $XXXXXXXXXXXXX -$34%
1 Year: $XXXXXXXXXXXXX -$47%
1-Year High: $XXXXXXXXXXXXX on 2024-09-06
1-Year Low: $XXXXXXXXXXXXX on 2025-05-15

Top assets mentioned In the posts about Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

Regeneron Pharmaceuticals Inc (REGN) GSK plc (GSK) Akropolis (AKRO) BounceBit (BB) Sleepless AI (AI) Neurocrine Biosciences, Inc. (NBIX) SuperRare (RARE) Agnico Eagle Mines Ltd. (AEM) Sarepta Therapeutics, Inc. (SRPT)

Top topics mentioned In the posts about Apellis Pharmaceuticals, Inc. Common Stock in the last XX hours

nvda, coins ai, spx, alt, $asnd, gme, $rhhby, qqq, $regn, amzn, aes, stocks, $repl, pltr, $gsk, $qntm, vera, $kalv, op, $tnxp, adm, qbts, $1211hk, byd, nke, $akro, $mgx, $edit, meta, $ocul, hims, nasdaq, $dwac, $bb, $ai, plug, $mirm, $urgn, $rgnx, $pure, $prax, clsk, $vrna, $nbix, asts, dawn, $wppl, oscr, apt, $inmb, sonn, money, stockmarket, mauritian rupee, luv, uber eats, nio, lmt, $veon, $lyel, $daaqw, dd, bbgi, $exk, $dea, pfe, hae, $futu, $fsm, $capr, $tvtx, $rare, $alec, $nvct, $bstz, $aem, $tars, approved, goog, radar, $srpt, $srzn, $eypt, $olma, $pmtrw, $emcg, $goss, $dkl, $tlry, $trv, $rost, $mcrp, $avxl, $obsv, $xlo, telo, mira, $mth, $mcrb, $imcr

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$APH -Evercore raises Amphenol target to $XXX from $XXX Outperform - $APLS -Baird raises Apellis Pharmaceuticals target to $XX from $XX Outperform - $AVDL -HC Wainwright initiates Avadel Pharmaceuticals coverage at Buy $XX target -"
@MarcJacksonLA on X 2025-07-18 17:08:22 UTC 7056 followers, XXX engagements

"#ThinkSabio #Trendingstock $SPX $SPY $XBI $QQQ $IWM #Markets #StockMarket #Stocks #Trending @BiO Upcoming Catalyst of Next Week 20-27 2025: July 22: $ONCY $REPL July 23: $GSK July 27: $INMB $ASND $CRVO July 28: $APLS"
@thinksabio on X 2025-07-18 16:55:19 UTC XXX followers, XXX engagements

"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"
@pick1998_2 on X 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements

"$APLS new alerts have been posted in the last hours-"
@HenriettaBrid19 on X 2025-07-18 14:31:38 UTC XX followers, XX engagements

Apellis Pharmaceuticals, Inc. Common Stock (APLS)
/topic/$apls